Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Patient characteristics
| Variables | Overall (n = 43) |
|---|---|
| Age (year), median (IQR) | 66 (32–86) |
| Sex | |
| Male | 35 |
| Female | 8 |
| Pathological tissue | |
| Clear cell | 39 |
| Papillary type 2 + sarcomatoid change | 1 |
| Fumarate hydratase-deficient | 1 |
| Collecting duct | 1 |
| unclassified | 1 |
| Treatment details | |
| 1st line | 20 |
| 2nd line or more | 23 |
| Medicated drugs | |
| Nivolumab + ipilimumab | 15 |
| Nivolumab alone | 23 |
| Pembrolizumab + axitinib | 4 |
| Avelumab + axitinib | 1 |
| IMDC classification | |
| Poor | 7 |
| Intermediate | 30 |
| Favorable | 6 |
